{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:07:14Z","timestamp":1777871234083,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,30]]},"DOI":"10.7759\/cureus.108039","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T17:06:46Z","timestamp":1777568806000},"source":"Crossref","is-referenced-by-count":0,"title":["Vonoprazan vs Proton Pump Inhibitors for Gastroprotection in Anticoagulated Patients: A Real-World Cohort Study"],"prefix":"10.7759","author":[{"given":"Hatem","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imad","family":"Alabdul Razzak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eyad","family":"Abdulrazzak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameh","family":"Gomaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khloud","family":"Abdelrazeq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annapurna","family":"Korimilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risha","family":"Khetarpal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motaz","family":"Almahmood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aamir","family":"Shahzad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaled","family":"Elsokary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1399955","article-title":"Exploring bleeding in oral anticoagulant users: assessing incidence by indications and risk factors in the entire nationwide cohort","volume":"15","author":"Jeong J","year":"2024","unstructured":"Jeong J, Heo KN, Lee S, Ah YM, Min S, Han JM, Lee JY. Exploring bleeding in oral anticoagulant users: assessing incidence by indications and risk factors in the entire nationwide cohort. Front Pharmacol. 2024, 15:1399955. 10.3389\/fphar.2024.1399955","journal-title":"Front Pharmacol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2022.06.033","article-title":"Warfarin is associated with higher rates of upper but not lower gastrointestinal bleeding compared with direct oral anticoagulants: a population-based propensity-weighted cohort study","volume":"21","author":"Ingason AB","year":"2023","unstructured":"Ingason AB, Hreinsson JP, Agustsson AS, et al.. Warfarin is associated with higher rates of upper but not lower gastrointestinal bleeding compared with direct oral anticoagulants: a population-based propensity-weighted cohort study. Clin Gastroenterol Hepatol. 2023, 21:347-357.e10. 10.1016\/j.cgh.2022.06.033","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2020.11.014","article-title":"Gastroprotection in patients on antiplatelet and\/or anticoagulant therapy: a position paper of National Association of Hospital Cardiologists (ANMCO) and the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO)","volume":"85","author":"Abrignani MG","year":"2021","unstructured":"Abrignani MG, Gatta L, Gabrielli D, et al.. Gastroprotection in patients on antiplatelet and\/or anticoagulant therapy: a position paper of National Association of Hospital Cardiologists (ANMCO) and the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO). Eur J Intern Med. 2021, 85:1-13. 10.1016\/j.ejim.2020.11.014","journal-title":"Eur J Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2018.1461835","article-title":"Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine","volume":"14","author":"El Rouby N","year":"2018","unstructured":"El Rouby N, Lima JJ, Johnson JA. Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine. Expert Opin Drug Metab Toxicol. 2018, 14:447-60. 10.1080\/17425255.2018.1461835","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-016-0718-z","article-title":"Effective and safe proton pump inhibitor therapy in acid-related diseases - a position paper addressing benefits and potential harms of acid suppression","volume":"14","author":"Scarpignato C","year":"2016","unstructured":"Scarpignato C, Gatta L, Zullo A, Blandizzi C. Effective and safe proton pump inhibitor therapy in acid-related diseases - a position paper addressing benefits and potential harms of acid suppression. BMC Med. 2016, 14:179. 10.1186\/s12916-016-0718-z","journal-title":"BMC Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2007.02889.x","article-title":"Effect of timing of dosing in relation to food intake on the pharmacokinetics of esomeprazole","volume":"64","author":"Sostek MB","year":"2007","unstructured":"Sostek MB, Chen Y, Andersson T. Effect of timing of dosing in relation to food intake on the pharmacokinetics of esomeprazole. Br J Clin Pharmacol. 2007, 64:386-90. 10.1111\/j.1365-2125.2007.02889.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5056\/jnm18029","article-title":"Potent potassium-competitive ACID blockers: a new era for the treatment of acid-related diseases","volume":"24","author":"Oshima T","year":"2018","unstructured":"Oshima T, Miwa H. Potent potassium-competitive ACID blockers: a new era for the treatment of acid-related diseases. J Neurogastroenterol Motil. 2018, 24:334-44. 10.5056\/jnm18029","journal-title":"J Neurogastroenterol Motil"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.01.018","article-title":"Update on the use of vonoprazan: a competitive acid blocker","volume":"154","author":"Graham DY","year":"2018","unstructured":"Graham DY, Dore MP. Update on the use of vonoprazan: a competitive acid blocker. Gastroenterology. 2018, 154:462-6. 10.1053\/j.gastro.2018.01.018","journal-title":"Gastroenterology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.1009","article-title":"The effect of food on the pharmacokinetics of the potassium-competitive acid blocker vonoprazan","volume":"11","author":"Mulford DJ","year":"2022","unstructured":"Mulford DJ, Leifke E, Hibberd M, Howden CW. The effect of food on the pharmacokinetics of the potassium-competitive acid blocker vonoprazan. Clin Pharmacol Drug Dev. 2022, 11:278-84. 10.1002\/cpdd.1009","journal-title":"Clin Pharmacol Drug Dev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.09.041","article-title":"Vonoprazan versus lansoprazole for healing and maintenance of healing of erosive esophagitis: a randomized trial","volume":"164","author":"Laine L","year":"2023","unstructured":"Laine L, DeVault K, Katz P, Mitev S, Lowe J, Hunt B, Spechler S. Vonoprazan versus lansoprazole for healing and maintenance of healing of erosive esophagitis: a randomized trial. Gastroenterology. 2023, 164:61-71. 10.1053\/j.gastro.2022.09.041","journal-title":"Gastroenterology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13123606","article-title":"Efficacy of vonoprazan vs. intravenous proton pump inhibitor in prevention of re-bleeding of high-risk peptic ulcers: a randomized controlled pilot study","volume":"13","author":"Pattarapuntakul T","year":"2024","unstructured":"Pattarapuntakul T, Wong T, Wetwittayakhlang P, et al.. Efficacy of vonoprazan vs. intravenous proton pump inhibitor in prevention of re-bleeding of high-risk peptic ulcers: a randomized controlled pilot study. J Clin Med. 2024, 13:3606. 10.3390\/jcm13123606","journal-title":"J Clin Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2024.03.036","article-title":"Comparison of vonoprazan versus intravenous proton pump inhibitor for prevention of high-risk peptic ulcers rebleeding after successful endoscopic hemostasis: a multicenter randomized noninferiority trial","volume":"167","author":"Geeratragool T","year":"2024","unstructured":"Geeratragool T, Kaosombatwattana U, Boonchote A, et al.. Comparison of vonoprazan versus intravenous proton pump inhibitor for prevention of high-risk peptic ulcers rebleeding after successful endoscopic hemostasis: a multicenter randomized noninferiority trial. Gastroenterology. 2024, 167:778-787.e3. 10.1053\/j.gastro.2024.03.036","journal-title":"Gastroenterology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.2211-23","article-title":"Similar effect of vonoprazan and oral proton pump inhibitors for preventing rebleeding in cases of upper gastrointestinal bleeding","volume":"63","author":"Abe H","year":"2024","unstructured":"Abe H, Tarasawa K, Hatta W, et al.. Similar effect of vonoprazan and oral proton pump inhibitors for preventing rebleeding in cases of upper gastrointestinal bleeding. Intern Med. 2024, 63:911-8. 10.2169\/internalmedicine.2211-23","journal-title":"Intern Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0261703","article-title":"Efficacy of vonoprazan against bleeding from endoscopic submucosal dissection-induced gastric ulcers under antithrombotic medication: a cross-design synthesis of randomized and observational studies","volume":"16","author":"Hidaka Y","year":"2021","unstructured":"Hidaka Y, Imai T, Inaba T, Kagawa T, Omae K, Tanaka S. Efficacy of vonoprazan against bleeding from endoscopic submucosal dissection-induced gastric ulcers under antithrombotic medication: a cross-design synthesis of randomized and observational studies. PLoS ONE. 2021, 16:e0261703. 10.1371\/journal.pone.0261703","journal-title":"PLoS ONE"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2020.02.012","article-title":"Upper gastrointestinal bleeding in Japanese patients with ischemic heart disease receiving vonoprazan or a proton pump inhibitor with multiple antithrombotic agents: a nationwide database study","volume":"76","author":"Tsujita K","year":"2020","unstructured":"Tsujita K, Deguchi H, Uda A, Sugano K. Upper gastrointestinal bleeding in Japanese patients with ischemic heart disease receiving vonoprazan or a proton pump inhibitor with multiple antithrombotic agents: a nationwide database study. J Cardiol. 2020, 76:51-7. 10.1016\/j.jjcc.2020.02.012","journal-title":"J Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2021.06.032","article-title":"Vonoprazan versus proton pump inhibitors for postendoscopic submucosal dissection bleeding in the stomach: a multicenter population-based comparative study","volume":"95","author":"Shiratori Y","year":"2022","unstructured":"Shiratori Y, Niikura R, Ishii N, et al.. Vonoprazan versus proton pump inhibitors for postendoscopic submucosal dissection bleeding in the stomach: a multicenter population-based comparative study. Gastrointest Endosc. 2022, 95:72-9.e3. 10.1016\/j.gie.2021.06.032","journal-title":"Gastrointest Endosc"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-021-01781-4","article-title":"Prevention of delayed bleeding with vonoprazan in upper gastrointestinal endoscopic treatment","volume":"56","author":"Abe H","year":"2021","unstructured":"Abe H, Hatta W, Ogata Y, et al.. Prevention of delayed bleeding with vonoprazan in upper gastrointestinal endoscopic treatment. J Gastroenterol. 2021, 56:640-50. 10.1007\/s00535-021-01781-4","journal-title":"J Gastroenterol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-015-0368-z","article-title":"Vonoprazan: first global approval","volume":"75","author":"Garnock-Jones KP","year":"2015","unstructured":"Garnock-Jones KP. Vonoprazan: first global approval. Drugs. 2015, 75:439-43. 10.1007\/s40265-015-0368-z","journal-title":"Drugs"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.11.007","article-title":"Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants","volume":"13","author":"Lanas \u00c1","year":"2015","unstructured":"Lanas \u00c1, Carrera-Lasfuentes P, Arguedas Y, et al.. Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants. Clin Gastroenterol Hepatol. 2015, 13:906-12.e2. 10.1016\/j.cgh.2014.11.007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.7326\/M21-1474","article-title":"Rivaroxaban is associated with higher rates of gastrointestinal bleeding than other direct oral anticoagulants: a nationwide propensity score-weighted study","volume":"174","author":"Ingason AB","year":"2021","unstructured":"Ingason AB, Hreinsson JP, \u00c1g\u00fastsson AS, et al.. Rivaroxaban is associated with higher rates of gastrointestinal bleeding than other direct oral anticoagulants: a nationwide propensity score-weighted study. Ann Intern Med. 2021, 174:1493-502. 10.7326\/M21-1474","journal-title":"Ann Intern Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.17242","article-title":"Association of oral anticoagulants and proton pump inhibitor cotherapy with hospitalization for upper gastrointestinal tract bleeding","volume":"320","author":"Ray WA","year":"2018","unstructured":"Ray WA, Chung CP, Murray KT, Smalley WE, Daugherty JR, Dupont WD, Stein CM. Association of oral anticoagulants and proton pump inhibitor cotherapy with hospitalization for upper gastrointestinal tract bleeding. JAMA. 2018, 320:2221-30. 10.1001\/jama.2018.17242","journal-title":"JAMA"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht042","article-title":"Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy","volume":"34","author":"Agewall S","year":"2013","unstructured":"Agewall S, Cattaneo M, Collet JP, et al.. Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy. Eur Heart J. 2013, 34:1708-13, 13a-b. 10.1093\/eurheartj\/eht042","journal-title":"Eur Heart J"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00053","article-title":"Cytochrome P450-based drug-drug interactions of vonoprazan in vitro and in vivo","volume":"11","author":"Wang Y","year":"2020","unstructured":"Wang Y, Wang C, Wang S, et al.. Cytochrome P450-based drug-drug interactions of vonoprazan in vitro and in vivo. Front Pharmacol. 2020, 11:53. 10.3389\/fphar.2020.00053","journal-title":"Front Pharmacol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.863","article-title":"Comparative study of effects of vonoprazan and esomeprazole on antiplatelet function of clopidogrel or prasugrel in relation to CYP2C19 genotype","volume":"103","author":"Kagami T","year":"2018","unstructured":"Kagami T, Yamade M, Suzuki T, et al.. Comparative study of effects of vonoprazan and esomeprazole on antiplatelet function of clopidogrel or prasugrel in relation to CYP2C19 genotype. Clin Pharmacol Ther. 2018, 103:906-13. 10.1002\/cpt.863","journal-title":"Clin Pharmacol Ther"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10173964","article-title":"Drug-drug interaction between tacrolimus and vonoprazan in kidney transplant recipients","volume":"10","author":"Suzuki Y","year":"2021","unstructured":"Suzuki Y, Yoshihashi T, Takahashi K, Furuya K, Ohkohchi N, Oda T, Homma M. Drug-drug interaction between tacrolimus and vonoprazan in kidney transplant recipients. J Clin Med. 2021, 10:3964. 10.3390\/jcm10173964","journal-title":"J Clin Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/488333-vonoprazan-vs-proton-pump-inhibitors-for-gastroprotection-in-anticoagulated-patients-a-real-world-cohort-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T17:06:46Z","timestamp":1777568806000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/488333-vonoprazan-vs-proton-pump-inhibitors-for-gastroprotection-in-anticoagulated-patients-a-real-world-cohort-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.108039","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,30]]}}}